Pharming Group N.V.
General ticker "PHGUF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $943.2M (TTM average)
Pharming Group N.V. follows the US Stock Market performance with the rate: 45.4%.
Estimated limits based on current volatility of 2.9%: low 1.62$, high 1.70$
Factors to consider:
- Earnings expected soon, date: 2026-05-07 bmo
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.26$, 2.54$]
- 2026-12-31 to 2027-12-31 estimated range: [1.24$, 2.49$]
Short-term PHGUF quotes
Long-term PHGUF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $245.32MM | $297.20MM | $391.32MM |
| Operating Expenses | $250.70MM | $300.71MM | $371.23MM |
| Operating Income | $-5.39MM | $-3.51MM | $20.09MM |
| Non-Operating Income | $-6.62MM | $-4.98MM | $-6.73MM |
| Interest Expense | $5.96MM | $9.52MM | $18.87MM |
| R&D Expense | $68.91MM | $83.15MM | $104.42MM |
| Income(Loss) | $-12.01MM | $-8.49MM | $13.37MM |
| Taxes | $-1.46MM | $3.35MM | $10.73MM |
| Profit(Loss)* | $-10.77MM | $-11.33MM | $2.97MM |
| Stockholders Equity | $218.78MM | $221.06MM | $277.03MM |
| Inventory | $56.76MM | $55.72MM | $64.89MM |
| Assets | $462.85MM | $411.25MM | $499.84MM |
| Operating Cash Flow | $-17.30MM | $-1.79MM | $51.94MM |
| Capital expenditure | $1.46MM | $0.76MM | $0.78MM |
| Investing Cash Flow | $-129.39MM | $31.62MM | $19.12MM |
| Financing Cash Flow | $-0.94MM | $-34.41MM | $15.02MM |
| Earnings Per Share** | $-0.02 | $-0.02 | $0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.